Tocilizumab
Form: IV injection, SQ Injection
Strength: IV: 80 mg/4 mL, 200 mg/10 mL, 400 mg/20 mL; SQ: 162 mg/0.9 mL (pen or syringe)
Reference Brands: Actemra®(US); RoActemra®(EU)
Category: Anti Covid Medicines
Tocilizumab (brand name Actemra or RoActemra) is a monoclonal antibody used to treat severe COVID-19 complications and autoimmune conditions like rheumatoid arthritis. Available in intravenous (IV) and subcutaneous (SC) forms, it comes in strengths such as 80 mg, 200 mg, 400 mg IV vials, and 162 mg SC pens/syringes. Approved in the US, EU, and global markets, Tocilizumab is in high demand for hospitals and critical care. Through trusted PharmaB2B platforms, buyers can connect with certified Tocilizumab manufacturers, exporters, and distributors, ensuring regulatory-compliant sourcing, bulk availability, and fast international delivery for institutional and government tenders.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Related Products
Baricitinib
Strength: 2 mg, 4 mg
Form: Tablet
Reference Brands: Olumiant®(EU & US- Emergency Use Authorization (EUA)
View Details Get Enquiry
Nirmatrelvir + Ritonavir
Strength: Nirmatrelvir(150 mg) + Ritonavir(100 mg)
Form: Tablet
Reference Brands: Paxlovid®(US & EU- For Emergency Use Authorization)
View Details Get Enquiry
Molnupiravir
Strength: 200 mg
Form: Oral capsule
Reference Brands: Lagevrio®(Us & EU)
View Details Get Enquiry
Favipiravir tablet
Strength: 200 mg, 400 mg, 600 mg
Form: Tablet
Reference Brands: Fabiflu, Favicovid, Covihalt, Avifavir, Avigan, Favira , Favilow(Globally, Not approved in USA & EU)
View Details Get Enquiry